nuclear factor kappa-light-chain-enhancer of activated B cells
Showing 1 - 25 of >10,000
Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)
Recruiting
- Lymphoma
- +2 more
- Kappa CD28 T cells
-
Houston, Texas
- +1 more
Jan 31, 2022
Breast Cancer Trial in Chapel Hill (surgery, therapy, radiation therapy)
Active, not recruiting
- Breast Cancer
- surgery
- +2 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Dec 20, 2022
Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals
Not yet recruiting
- Preterm Labor
- (no location specified)
May 9, 2023
Thyroid Diseases, Hypothyroidism, Hashimoto Disease Trial in Tehran (curcumin, Anti-inflammatory diet)
Not yet recruiting
- Thyroid Diseases
- +2 more
- curcumin
- Anti-inflammatory diet
-
Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic ofGolbon Sohrab
Jul 27, 2023
Healthy Volunteers Trial in Daytona Beach (iCP-NI, Placebo)
Recruiting
- Healthy Volunteers
- iCP-NI
- Placebo
-
Daytona Beach, FloridaLabcorp Clinical Research Unit Inc.
Feb 21, 2023
Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)
Not yet recruiting
- Breast Cancer Stage 2 and 3
- Fenofibrate
- +3 more
- (no location specified)
Nov 24, 2023
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Not yet recruiting
- Metastatic Colon Adenocarcinoma
- +6 more
- Balstilimab
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 17, 2022
iMmune Function in Post-surgical and AuToimmune
Completed
- Hypoparathyroidism
- +2 more
-
Rome, ItalyDepartment of Experimental Medicine, "Sapienza" University of Ro
Dec 4, 2022
Aging and Gender-Affirming Hormone Therapy on Vascular
Recruiting
- Transgenderism
- +6 more
-
Aurora, ColoradoUniversity of Colorado
Oct 31, 2022
Peri-Implantitis Trial in Van (Er, Cr: YSGG laser-assisted non-surgical mechanical therapy, Non-surgical mechanical therapy)
Completed
- Peri-Implantitis
- Er, Cr: YSGG laser-assisted non-surgical mechanical therapy
- Non-surgical mechanical therapy
-
Van, TurkeyNazli Zeynep Alpaslan
Sep 13, 2023
Orchiectomy and Age on Vascular and Metabolic Health in Older
Recruiting
- Transgender
- +7 more
-
Aurora, ColoradoUniversity of Colorado
Jan 28, 2022
COVID-19 Transmission and Morbidity in Malawi
Recruiting
- SARS CoV 2 Infection
- SARS CoV 2 Vaccination
-
Boston, Massachusetts
- +1 more
Aug 6, 2023
Diabetic Neuropathy Peripheral Trial in Cairo (Ambroxol Oral Product)
Not yet recruiting
- Diabetic Neuropathy Peripheral
- Ambroxol Oral Product
-
Cairo, EgyptAin Shams university Hospital
Sep 27, 2022
Non-alcoholic Steatohepatitis Trial (Rosuvastatin 20mg, N-acetyl cysteine, Rosuvastatin and N-acetyl cysteine)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- Rosuvastatin 20mg
- +3 more
- (no location specified)
Oct 29, 2023
Adenocarcinoma of the Prostate Trial in United States (Muscadine Plus, Placebos)
Terminated
- Adenocarcinoma of the Prostate
- Muscadine Plus
- Placebos
-
Duarte, California
- +12 more
Dec 6, 2022
Periodontitis Trial in Cairo (Lepidium Sativum, Simvastatin)
Completed
- Periodontitis
- Lepidium Sativum
- Simvastatin
-
Cairo, EgyptFaculty of Dentitry, Ain Shams University
Dec 10, 2022
Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,
Recruiting
- Mantle Cell Lymphoma
- +5 more
- CAR.k.28
- +3 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Nov 19, 2021
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Dexamethasone
- +2 more
-
Atlanta, Georgia
- +3 more
Jan 6, 2023
Overweight or Obesity, Healthy Trial in Chicago (Mango, Control)
Recruiting
- Overweight or Obesity
- Healthy
- Mango
- Control
-
Chicago, IllinoisClinical Nutrition Research Center
Apr 14, 2021
Primary CNS Lymphoma Trial in San Francisco (Hyperpolarized pyruvate (13C), Magnetic resonance imaging (MRI))
Recruiting
- Primary CNS Lymphoma
- Hyperpolarized pyruvate (13C)
- Magnetic resonance imaging (MRI)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 22, 2022
Aging and Gender-Affirming Hormone Therapy on Vascular
Recruiting
- Transgenderism
- +7 more
-
Aurora, ColoradoUniversity of Colorado
Oct 22, 2021